DAXOR CORP (DXR) Fundamental Analysis & Valuation

NASDAQ:DXR • US2394671034

Current stock price

10.94 USD
-0.18 (-1.62%)
Last:

This DXR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. DXR Profitability Analysis

1.1 Basic Checks

  • In the past year DXR was profitable.
  • In the past year DXR had a positive cash flow from operations.
  • DXR had positive earnings in each of the past 5 years.
  • In multiple years DXR reported negative operating cash flow during the last 5 years.
DXR Yearly Net Income VS EBIT VS OCF VS FCFDXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M

1.2 Ratios

  • DXR's Return On Assets of 19.93% is amongst the best of the industry. DXR outperforms 98.91% of its industry peers.
  • DXR has a Return On Equity of 19.98%. This is amongst the best in the industry. DXR outperforms 94.02% of its industry peers.
Industry RankSector Rank
ROA 19.93%
ROE 19.98%
ROIC N/A
ROA(3y)7.4%
ROA(5y)11.66%
ROE(3y)7.44%
ROE(5y)12.51%
ROIC(3y)N/A
ROIC(5y)N/A
DXR Yearly ROA, ROE, ROICDXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • DXR's Profit Margin of 34343.82% is amongst the best of the industry. DXR outperforms 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of DXR has grown nicely.
  • DXR does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 34343.82%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y147.98%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DXR Yearly Profit, Operating, Gross MarginsDXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10K 20K 30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. DXR Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, DXR has more shares outstanding
  • DXR has more shares outstanding than it did 5 years ago.
  • DXR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DXR Yearly Shares OutstandingDXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M
DXR Yearly Total Debt VS Total AssetsDXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • DXR has an Altman-Z score of 318.25. This indicates that DXR is financially healthy and has little risk of bankruptcy at the moment.
  • DXR's Altman-Z score of 318.25 is amongst the best of the industry. DXR outperforms 100.00% of its industry peers.
  • DXR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 318.25
ROIC/WACCN/A
WACCN/A
DXR Yearly LT Debt VS Equity VS FCFDXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 0.08 indicates that DXR may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.08, DXR is doing worse than 96.74% of the companies in the same industry.
  • DXR has a Quick Ratio of 0.08. This is a bad value and indicates that DXR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.08, DXR is not doing good in the industry: 96.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
DXR Yearly Current Assets VS Current LiabilitesDXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. DXR Growth Analysis

3.1 Past

  • DXR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1068.54%, which is quite impressive.
  • DXR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.41% yearly.
  • The Revenue for DXR has decreased by -77.71% in the past year. This is quite bad
  • DXR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.57% yearly.
EPS 1Y (TTM)1068.54%
EPS 3Y14.41%
EPS 5YN/A
EPS Q2Q%329.99%
Revenue 1Y (TTM)-77.71%
Revenue growth 3Y-51.22%
Revenue growth 5Y-36.57%
Sales Q2Q%-82.71%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-425%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year70%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DXR Yearly Revenue VS EstimatesDXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
DXR Yearly EPS VS EstimatesDXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2025 2026 0 0.05 -0.05 -0.1 -0.15 -0.2

More info and screens

Find the best growth stocksShow best growing peers

4

4. DXR Valuation Analysis

4.1 Price/Earnings Ratio

  • DXR is valuated cheaply with a Price/Earnings ratio of 5.53.
  • 97.28% of the companies in the same industry are more expensive than DXR, based on the Price/Earnings ratio.
  • DXR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.23.
  • DXR is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 5.53
Fwd PE N/A
DXR Price Earnings VS Forward Price EarningsDXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, DXR is valued a bit cheaper than 69.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 111.72
EV/EBITDA N/A
DXR Per share dataDXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DXR Dividend Analysis

5.1 Amount

  • DXR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DXR Fundamentals: All Metrics, Ratios and Statistics

DAXOR CORP

NASDAQ:DXR (3/20/2026, 8:00:01 PM)

10.94

-0.18 (-1.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-04
Earnings (Next)N/A
Inst Owners1.45%
Inst Owner Change14.28%
Ins Owners5.08%
Ins Owner Change0.41%
Market Cap63.78M
Revenue(TTM)26.70K
Net Income(TTM)9.17M
Analysts80
Price Target23.8 (117.55%)
Short Float %0.12%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.71%
PT rev (3m)-0.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.53
Fwd PE N/A
P/S 2388.77
P/FCF 111.72
P/OCF 111.72
P/B 1.39
P/tB 1.39
EV/EBITDA N/A
EPS(TTM)1.98
EY18.1%
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)0.1
FCFY0.9%
OCF(TTM)0.1
OCFY0.9%
SpS0
BVpS7.87
TBVpS7.87
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.73
Profitability
Industry RankSector Rank
ROA 19.93%
ROE 19.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 34343.82%
GM N/A
FCFM 2138.2%
ROA(3y)7.4%
ROA(5y)11.66%
ROE(3y)7.44%
ROE(5y)12.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y147.98%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 6.23%
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z 318.25
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1068.54%
EPS 3Y14.41%
EPS 5YN/A
EPS Q2Q%329.99%
EPS Next Y-425%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-77.71%
Revenue growth 3Y-51.22%
Revenue growth 5Y-36.57%
Sales Q2Q%-82.71%
Revenue Next Year70%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2121.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2121.4%
OCF growth 3YN/A
OCF growth 5YN/A

DAXOR CORP / DXR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DAXOR CORP?

ChartMill assigns a fundamental rating of 4 / 10 to DXR.


Can you provide the valuation status for DAXOR CORP?

ChartMill assigns a valuation rating of 4 / 10 to DAXOR CORP (DXR). This can be considered as Fairly Valued.


Can you provide the profitability details for DAXOR CORP?

DAXOR CORP (DXR) has a profitability rating of 4 / 10.


How financially healthy is DAXOR CORP?

The financial health rating of DAXOR CORP (DXR) is 5 / 10.


Can you provide the dividend sustainability for DXR stock?

The dividend rating of DAXOR CORP (DXR) is 0 / 10 and the dividend payout ratio is 0%.